Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriatic Plaque”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableLooking for participantsNCT06382051
What this trial is testing

Modifying PEST for Psoriatic Arthritis Screening

Who this might be right for
Plaque PsoriasisPsoriatic Arthritis
Novartis Pharmaceuticals 502
Early research (Phase 1)Looking for participantsNCT06888193
What this trial is testing

Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL 20
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Testing effectiveness (Phase 2)Study completedNCT01987609
What this trial is testing

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

Who this might be right for
Psoriasis
Tissa Hata, MD 7
Large-scale testing (Phase 3)Study completedNCT01365455
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 738
Testing effectiveness (Phase 2)Study completedNCT02180464
What this trial is testing

A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis

Who this might be right for
Psoriasis
Almirall, S.A. 40
Post-approval studies (Phase 4)WithdrawnNCT04488185
What this trial is testing

An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Not applicableWithdrawnNCT04099979
What this trial is testing

A Pilot Study to Explore the Role of Gut Flora in Psoriasis

Who this might be right for
PsoriasisPsoriasis VulgarisPsoriasis Universalis+11 more
ProgenaBiome
Post-approval studies (Phase 4)Study completedNCT04183881
What this trial is testing

Clinical Study of Brodalumab

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more
Kyowa Kirin Co., Ltd. 138
Post-approval studies (Phase 4)Study completedNCT02148640
What this trial is testing

The NOR-SWITCH Study

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis+3 more
Diakonhjemmet Hospital 482
Large-scale testing (Phase 3)Ended earlyNCT00090129
What this trial is testing

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Arthritis, Psoriatic
EMD Serono 854
Not applicableStudy completedNCT05155098
What this trial is testing

2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAnkylosing Spondylitis+1 more
Novartis Pharmaceuticals 127
Large-scale testing (Phase 3)Study completedNCT02714322
What this trial is testing

MYL-1401A Efficacy and Safety Comparability Study to Humira®

Who this might be right for
PsoriasisArthritis, Psoriatic
Mylan Inc. 294
Not applicableStudy completedNCT04614831
What this trial is testing

A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis

Who this might be right for
Plaque Psoriasis, Psoriatic Arthritis
Novartis Pharmaceuticals 4,978
Testing effectiveness (Phase 2)Study completedNCT01872546
What this trial is testing

Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy

Who this might be right for
Chronic Plaque Psoriasis
Poitiers University Hospital 18
Testing effectiveness (Phase 2)Study completedNCT02416258
What this trial is testing

A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)

Who this might be right for
Skin and Connective Tissue Diseases
LEO Pharma 50
Early research (Phase 1)Study completedNCT06291948
What this trial is testing

A Clinical Study With Adalimumab Biosimilar

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 150
Post-approval studies (Phase 4)Looking for participantsNCT07611747
What this trial is testing

Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)

Who this might be right for
Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondy+4 more
Instituto de Investigación Marqués de Valdecilla 1,944
Testing effectiveness (Phase 2)Ended earlyNCT00954915
What this trial is testing

Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis

Who this might be right for
Psoriasis
MacroGenics 1
Not applicableNot Yet RecruitingNCT06802848
What this trial is testing

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

Who this might be right for
Plaque PsoriasisPsoriatic ArthritisScalp Psoriasis+3 more
Chongqing Genrix Biopharmaceutical Co., Ltd 1,000
Next Page